Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake
NCT ID: NCT02568592
Last Updated: 2016-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2015-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Endurance performance and the ability to burn fat will be measured in women runners following the consumption of 3 diets varying in the amount of fat and carbohydrate.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Body Weight and Carb Metabolism
NCT05330481
Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity
NCT01451957
Physiological and Sensory Responses to Prolonged Fasting in Humans
NCT05977569
Intermittent Carbohydrate Restriction in Cardiometabolic Health
NCT06684834
Effect of a Mixed Macronutritional Meal With Medium Chain Triglycerides on the Oxidation of Postprandial Macronutrients
NCT04321018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Fat
High Fat - Carbohydrate (20%), Fat (65%), Protein (15%)
High Fat
High Fat - Carbohydrate (20%), Fat (65%), Protein (15%)
Normal
Normal - Carbohydrate (50%), Fat (35%) and Protein (15%)
Normal
Normal - Carbohydrate (50%), Fat (35%) and Protein (15%)
Normal + Extra Fat
Normal + Extra Fat - Carbohydrate (50%), Fat (65%), Protein (15%). Carbohydrate and protein intake identical in absolute amounts to NORM (Normal), with an additional 30% extra energy coming from fat.
Normal + Extra Fat
Normal + Extra Fat - Carbohydrate (50%), Fat (65%), Protein (15%). Carbohydrate and protein intake identical in absolute amounts to NORMAL, with an additional 30% extra energy coming from fat.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Fat
High Fat - Carbohydrate (20%), Fat (65%), Protein (15%)
Normal
Normal - Carbohydrate (50%), Fat (35%) and Protein (15%)
Normal + Extra Fat
Normal + Extra Fat - Carbohydrate (50%), Fat (65%), Protein (15%). Carbohydrate and protein intake identical in absolute amounts to NORMAL, with an additional 30% extra energy coming from fat.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good General Health
* Accustomed to vigorous physical activity
* Run \> 2 times per week
* V̇O2max \>50ml/kg/min
* Weight Stable \> last 6months
* Non Smoker
* Pre-menopausal, and either eumenorrheic and regularly menstruating, or using monophasic hormonal oral contraceptives for \> 3 months.
Exclusion Criteria
* Taking any prescription drug / supplement thought to influence metabolism
* Following unusual dietary practices (such as intermittent fasting or low carbohydrate diets)
* Pregnant
* Breast Feeding
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
University of Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gareth A Wallis, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Birmingham
Birmingham, West Midlands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERN_15-0012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.